Abbott and Alere amend acquisition terms, drop lawsuits

Abbott and Alere announced amended terms for Abbott's pending acquisition of Alere. Abbott will pay $51 per share for an expected equity value of $5.3 billion, down from $5.8 billion. The companies have dismissed lawsuits against each other and extended the regulatory approval deadline to September 30, 2017.

“Abbott and Alere announced that the terms for Abbott’s pending acquisition of Alere have been amended and the companies have ceased litigation against each other.”healio.com

• 1 source
• healio.comTerms of Abbott acquisition of Alere changed, lawsuits droppedApr 23, 2017

Summarized from public sources; check the original articles before acting on it.